chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt came in to be seen today because he showed up on a list being delinquent for an Anthrax vaccine. After restarting the Anthrax regime last year, pt states he has been having unknown pains in his arms, back and legs. After several visits and a referral to a board certified Rheumatoloist it has been determined that the Anthrax vaccne most likely has caused his unknown pains and is recommended pt be deferred from any additional Anthrax shots.
Patient reported daily headaches since vaccine was given that are relieved by Tylenol and Ibuprofen, but then will come back. Apparently, this happened after her 3rd dose in 11/21 for two or more weeks, but she never reported it. I encouraged her to download Vsafe for reporting purposes/tracking and also submit to VAERS, as she is a healthcare professional as well.
pt @ noon on 7/28/99 noted weakness of facial muscles; condition worsened on 7/29; et ct was seen in ER where dx of bell's palsy was made
Discoloration; Bruised circular area; Had a red welt about golf ball diameter sized; Redness; Swelling; Just sore; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of SKIN DISCOLOURATION (Discoloration), CONTUSION (Bruised circular area), VACCINATION SITE PAIN (Just sore), VACCINATION SITE URTICARIA (Had a red welt about golf ball diameter sized) and VACCINATION SITE ERYTHEMA (Redness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026L20A and 030L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 30-Dec-2020, the patient experienced VACCINATION SITE PAIN (Just sore). On 28-Jan-2021, the patient experienced VACCINATION SITE URTICARIA (Had a red welt about golf ball diameter sized), VACCINATION SITE ERYTHEMA (Redness) and VACCINATION SITE SWELLING (Swelling). On 08-Feb-2021, the patient experienced SKIN DISCOLOURATION (Discoloration) and CONTUSION (Bruised circular area). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN at an unspecified dose and frequency. At the time of the report, SKIN DISCOLOURATION (Discoloration), CONTUSION (Bruised circular area), VACCINATION SITE PAIN (Just sore), VACCINATION SITE URTICARIA (Had a red welt about golf ball diameter sized), VACCINATION SITE ERYTHEMA (Redness) and VACCINATION SITE SWELLING (Swelling) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was provided.
Morning after receiving vaccination pt reported waking with extremely swollen face and widespread, itchy hives over arms, trunk, and more. Sought medical tmt, rec'd steroids and antihistamines.
Pt. experienced mod. localized reaction to rt. arm; lump "the size of an Oreo cookie", with redness and heat from the area. Also, had itching/mild tingling. Tx'd at home w/anti-inflammatories and cool compresses.
This is in follow-up to report(s) previously submitted on 5/16/2008. Information has been received from a certified nurse midwife (CNM), for VARIVAX (Merck), via the Merck pregnancy registry product, concerning a 22 year old female patient with no pertinent medical history, who on 11-JAN-2008 was vaccinated with a dose of varicella virus vaccine live (Oka/Merck) (lot # not reported). There was no concomitant medication. On approximately 25-JAN-2008 (2 weeks after vaccination) the patient became pregnant. Subsequently the patient experienced spotting after intercourse, but was otherwise "doing well". A beta-human chorionic gonadotropin (HCG) test was normal, and an ultrasound "showed" the heartbeat (dates not reported). The estimated date of delivery was 15-OCT-2008 (estimated date of LMP 09-JAN-2008). Follow up information has been received from a certified nurse midwife via a telephone call, indicating the patient transferred her prenatal care at 34 weeks gestation. The reporter heard from another healthcare professional that the baby (L.D. # 47305)was fine and doing well. The reporter offered to contact the patient and asked her to call us and provided for specific information. Additional information has been requested.
Pfizer-BioNTech COVID-19 Vaccine EUA: patient reports fatigue, myalgias, chills, and a swollen arm (at injection site) starting one day after receiving vaccination. Patient previously had COVID-19. During clinic visit three days after vaccination symptoms have resolved without intervention.
All heart rate monitoring is from my smart watch which I wore for the duration of the event.  I had a fever since 7:30pm and was trying to sleep. ~10:35 pm I had been sleeping lightly for a couple of hours, but woke up and my heart rate was ~125bpm while laying down. My temperature was 100.8F. I needed to get some water, so I got up slowly and went to get some from my kitchen, only a few steps away from my bed. I began to feel slightly nauseous, so I looked at my watch to see my heart rate. It was 152 bpm. I went to lie back down. I had to get up several more times in the night and my heart rate always jumped to the upper 140s. I felt like I needed to go to the hospital but chose not to due to cost concerns.  I took 500mg of acetaminophen and was able to sleep for a few more hours. The next morning my heart rate was not jumping up as high when I stood up, although by that time I had begun taking acetaminophen every 6 hours which was helping with the fever. I still was unable to do my daily activities and kept movement to a minimum for the next 24 hours.
Swollen lymph nodes; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 59 year-old male patient received bnt162b2 (BNT162B2), administered in arm right, administration date Mar2021 (Lot number: EN6205) at the age of 59 years as dose 1, single and administered in arm right, administration date Mar2021 (Lot number: ER8727) as dose 2, single for covid-19 immunisation. Relevant medical history included: "Chronic obstructive pulmonary disease" (unspecified if ongoing). Concomitant medication(s) included: BENICAR. The following information was reported: LYMPHADENOPATHY (non-serious) with onset Mar2021, outcome "recovered" (2021), described as "Swollen lymph nodes". Therapeutic measures were not taken as a result of lymphadenopathy.  Additional Information: Hospitalization Prolonged was No. Did the patient receive any other vaccines within 4 weeks prior to the COVID vaccine was No. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. Reported Event: swollen lymph nodes. Reaction Start Date : Mar2021 02:00 AM  Follow-up attempts completed. No further information expected.
Arm was sore; She had problem with her ears; She had like echoing in her ears; She heard like a banging sound in her ears; This is a spontaneous report received from a contactable consumer. A 84-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/lot number: EN6205) via intramuscular route of administration at left deltoid on 12Mar2021 around 13:30 (at the age of 84-year-old) as dose 2, single for COVID-19 immunisation. Medical history included asthma, underactive thyroid, open heart surgery and aortic valve replacement on 14Feb2020 and she also had 24Feb2020 a pacemaker, acid reflux. Concomitant medications included warfarin, pantoprazole sodium sesquihydrate (PROTONIX [PANTOPRAZOLE SODIUM SESQUIHYDRATE]) taken 40mg, tablet, once a day for Acid reflux/ reporter states "it's pantoprazole", fluticasone propionate (FLONASE [FLUTICASONE PROPIONATE]) taken 50 mcg/reporter states "that's liquid spray in her nostril, two sprays every night" for asthma, warfarin (WARFARIN)/Reporter stated, she was taking blood thinners or Warfarin. Patient previously took bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Lot Number: EL9266) via intramuscular route of administration at right deltoid on 19Feb2021 (at the age of 84-year-old) as dose 1, single for COVID-19 immunisation. Reporter stated that she was wondering if you heard of any of the side effect from the Pfizer COVID 19 Vaccine. She was trying to look up online and her mother was 84, she had her second Pfizer Vaccination last Friday, she was 84 years old. So she got her second vaccination probably around 13:30 in the afternoon, she has mild, her arm was sore that was one thing, but around 10:30-11 o'clock at night, she had problem with her ears, so she had like echoing in her ears, she does not wear hear aid anything, but there was like echoing and she heard like a banging sound in her ears on Mar 2021, so she had that for a couple hours but then she laid down she went her bed and next morning she was fine. She reported it to her primary care physician so last night which was yesterday, one day before a week of the second vaccine she had, last night around 6:15 in the evening she had another bout of echoing in her ears. Could this be something from the Pfizer Vaccine, have you heard reports for that? Outcome of events was unknown.  No follow-up attempts are possible. No further information is expected.
NO ADVERSE EVENTS NOTED AT TIME OF COMPLETING THIS FORM. Patient was given 0.5ml of Fluzone on 26-Aug-2009 and then again on 02-Sep-2009.
pain radiating up her right arm (same arm as injection) to the shoulder and neck,; Nausea; General fatigue; Headache; Pain all over different parts of her body; Back pain, couldn't get out of bed; Left hip pain, that persisted and she could barely walk\ pain in ankle\pain in left elbow\shoulder pain; Neck and shoulder pain returned; Discomfort in right hand, knuckle tender to the touch; discomfort in her right hand where her knuckle was tender to the touch; This spontaneous case was reported by an other health care professional and describes the occurrence of PAIN IN EXTREMITY (pain radiating up her right arm (same arm as injection) to the shoulder and neck,), NAUSEA (Nausea), FATIGUE (General fatigue), HEADACHE (Headache) and MYALGIA (Pain all over different parts of her body) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (pain radiating up her right arm (same arm as injection) to the shoulder and neck,), NAUSEA (Nausea), FATIGUE (General fatigue), HEADACHE (Headache), MYALGIA (Pain all over different parts of her body), BACK PAIN (Back pain, couldn't get out of bed), ARTHRALGIA (Left hip pain, that persisted and she could barely walk\ pain in ankle\pain in left elbow\shoulder pain), NECK PAIN (Neck and shoulder pain returned), TENDERNESS (Discomfort in right hand, knuckle tender to the touch) and DISCOMFORT (discomfort in her right hand where her knuckle was tender to the touch). At the time of the report, PAIN IN EXTREMITY (pain radiating up her right arm (same arm as injection) to the shoulder and neck,), NAUSEA (Nausea), FATIGUE (General fatigue), HEADACHE (Headache), MYALGIA (Pain all over different parts of her body), BACK PAIN (Back pain, couldn't get out of bed), ARTHRALGIA (Left hip pain, that persisted and she could barely walk\ pain in ankle\pain in left elbow\shoulder pain), NECK PAIN (Neck and shoulder pain returned), TENDERNESS (Discomfort in right hand, knuckle tender to the touch) and DISCOMFORT (discomfort in her right hand where her knuckle was tender to the touch) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Mother reports child had fever of 104F, irritable and crying. On 3/3 dx with ear infection.
Pt called at 5 pm, approximately 7 hours after vaccine admin. about allergic rxn consisting of hives on head, swollen lips, and tingling in hands. I instructed pt to take BENADRYL - he had taken 2 tablets at 4 pm and reported improved/improving symptoms.
- 3"x6" raised, hot welt at injection site- still resolving 4 days after shot  -  Fever of 101 F for 2.5 days (partially resolved by Advil)  - Body aches and fatigue for 3 days then resolved - Uterine cramping with old-blood discharge (post-menopausal) started 2 days post vaccine. Unresolved at time of reporting.
Fever; Chills; Migraine; Vomiting; Nausea; Body aches; This is a spontaneous report received from a non-contactable pharmacist (patient, reported herself). A 33-year-old female (who was not pregnant at the time of vaccination), received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: 3n6203, and Expiration date was unknown), via an unspecified route of administration, in arm right, on 10Mar2021, 09:00 AM, as a single dose for COVID-19 immunization. Medical history included allergies to NSAIDs. Concomitant medications were not reported. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: El9266, and Expiration date was unknown), via an unspecified route of administration in right arm, on 17Feb2021 09:00 AM for COVID-19 immunization. Patient did receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient did not receive any other medications within 2 weeks of vaccination. The patient was not diagnosed with COVID-19, prior to vaccination. Since the vaccination, patient has not been tested for COVID-19. It was reported that on 10Mar2021 at 10:00 PM, the patient experienced Fever, Chills, Migraine, Vomiting, Nausea and Body aches. The patient was treated with Zofran ODT, Tylenol and oral rehydration as corrective treatment for the events. The outcome of the events was recovering.  No follow-up attempts are possible. No further information is expected.; Sender's Comments: The events was considered related to suspect drug based on strong temporal association and known safety profile of the drug. however, the contribution of underlying medical conditions cannot be excluded with the available information. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.
This case was reported by a other health professional via call center representative and described the occurrence of extensive swelling of vaccinated limb in a elderly female patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 2nd dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced extensive swelling of vaccinated limb and injection site erythema. On an unknown date, the outcome of the extensive swelling of vaccinated limb and injection site erythema were unknown. It was unknown if the reporter considered the extensive swelling of vaccinated limb and injection site erythema to be related to SHINGRIX. Additional details were provided as follows: This case was reported by a physician assistant. The age at vaccination was not reported. The patient experienced swelling and redness around injection site. It increased on the day of reporting to width 11 mm and length 12 cm. No further information was reported. The healthcare professional reported adverse event via click to chat forum.
Fever; Chills; Body aches; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration on 06Apr2021 at 18:45 (at the age of 46-year-old) as a single dose for COVID-19 immunisation. Medical history included Crohn's disease. Concomitant medications included ustekinumab (STELARA) from unknown dates for unspecified indication, last injection was on 05Mar2021. The patients allergies to food, medications, or other products was reported as N/a. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021 at 10:45, the patient experienced fever, chills and body aches starting 40 hours after vaccine and lasting 18 hours. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcome of the events fever, chills and body aches was recovered on 09Apr2021 at 04:45.   No follow-up attempts are needed. No further information is expected.
Headache, fever & chills for first two days: 4/14/21 &  4/15/21 Itchy rash started the morning of 4/15/21 and continues through today 4/19/21
Information has been received from a registered nurse referring to a patient of unknown age and gender. Information about concurrent conditions, medical history and concomitant medication was not provided. On 22-JAN-2016 the patient was administered with a dose of improperly stored GARDASIL 9 (lot# L004014 and expiration date 04-MAR-2016, dose, dose# and route not reported). No adverse effects reported. This is one of several reports received from the same source. Additional information is not expected since there was no consent for follow up contact.
Rash face and neck; This is a spontaneous report from a contactable Other Health Professional that reported for herself.  A 53-year-old female patient received dose 1 of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) Lot number EL8982 on 22JAN2021 15:00, as single dose (at the age of 53 years) via unspecified route in left arm for COVID-19 immunisation. The patient medical history was none. Concomitant medication was not reported. The patient was not pregnant at the time of vaccination.  There were no allergies to medications, food, or other products.  Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine.  Since the vaccination, the patient has not been tested for COVID-19. On 26Jan2021 at 06:00 the patient experienced Rash face and neck.  The patient received treatment (Benadryl and aloe).  The outcome rash face and neck are recovering. The case was reported as non-serious by the reporter.
Tingling lips; I thought maybe they (lips) were swollen just a little bit; Swelling in the left side of neck either in a lymph node or in that gland; Swelling in the left side of neck either in a lymph node or in that gland; Had some tightness when I was breathing deep, some tightness in lungs; Itching lips; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in Jan2021 11:45 AM at single dose for COVID-19 immunisation. The patient's medical history and patient's concomitant medications were not reported. In Jan2021 the patient had first Pfizer shot on Sunday at 11:45 AM. And then did not have any reaction to it that day. But later that night and early Monday morning had a little bit of tingling in lips and thought maybe they (lips) were swollen just a little bit. And had some swelling in the left side of neck either in a lymph node or in that gland. Then patient reported a little bit of swelling thought it was with the lymph node. And then had some tightness like when was breathing deep, some tightness in lungs. The patient asked if these are considered severe reactions or they just minor or what are they. The tingling in lips only lasted for just for itching or what, it only lasted only for a little while and the lymph node went back down after an hour or so. Outcome of other events was unknown.  Information on the lot/batch number has been requested.
Covid arm. Swelling, redness, warmth at the site of the injection. Started 5 days after injection and lasted 7 days.  Treated with antihistamine and warm compress.
pt recvd measles vax 24MAY91 & 30NOV91 lab eval showed no immunity; no further details were provided;
Nurse administered Moderna booster dose (0.25 mL) per parent request versus Pfizer booster, but patient only 14 years of age and therefore not eligible for Moderna vaccine.
Patient received pediatric dose of Hep A and should have received adult dose of Hep A
VASOVAGAL SYNCOPE FAINTNESS FOLLOWING 30 MINUTES AFTER VACCINATION
Developed symptoms two weeks later 12/01/2021, Acute lower back pain and inflammation, lasted two weeks 01/10/2022 developed left and right elbow joint pain. Recovered from back pain; however, not from the elbow joint pain in the left and right elbow joint. Still under going treatment for the elbow joint pain issues. Dr. visit for back pain 12/16/2021.
The firefighter noticed swelling and pain to his right axilla approximately 15 hours after administer of the vaccine. He also reported soreness to the right deltoid, but no redness to the site.
Significant lethary, very sore arm, muscle weakness, full body achiness. Currently ongoing.
she has phlegm in her throat without a fever; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EL3249), via an unspecified route of administration on 16Jan2021 as single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. It was reported that She received the 1st dose 3 weeks ago and is scheduled to have the 2nd dose tomorrow. She is concerned because she has phlegm in her throat without a fever and wanting to know if she can continue tomorrow with the shot or should she delay it. It was reported that she had the first dose of the vaccine and is scheduled to get the second dose of the vaccine tomorrow 06Feb2021. It was reported that today she has been clearing phlegm out of her throat and wants to know if she can get the second dose tomorrow. The outcome of event was unknown.  Follow-up attempts are completed. No further information is expected.
Vomiting x 2 days, 3FEB91 & 4FEB91-no fever or other sx; MGM stated while riding in car 4FEB91 w/grandparents child vomited then became limp, unresponsive & respirations became shallow. Taken to Hosp 8FEB91 severe diarrhea given Rocephin IV
Patient started coughing a few minutes after getting the flu shot. His breathing quickly became wheezy and the coughing grew worse. He had reacted to previous years flu shots with swelling and redness at the vaccination site. The nurse practitioner that administered the vaccine said that he was having a reaction and asked if we had epinephrine. She gave him oral Benadryl and I administered an Auviq auto injector at 1033 am. His coughing slowed as we rushed him to the er where they gave him oral steroids and a breathing treatment. He also developed a rash on his back and neck. His coughing resolved and he was kept for observation.
Arm extremely sore, fever of 101, ice to arm Tylenol/Advil for fever.